| Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725) |
|---|
| 06/04/2002 | US6399714 Crosslinked polyamide |
| 06/04/2002 | US6399700 Comb copolymers for regulating cell-surface interactions |
| 06/04/2002 | US6398758 Medicament delivery system |
| 05/30/2002 | WO2002013880A3 Bonding spacers to polymeric surfaces |
| 05/30/2002 | US20020064558 Copolymer of an alkoxyalkyl (meth)acrylate and a monomer having a basic functional group; biocompatibility |
| 05/29/2002 | EP1207915A1 Novel multilayered material bearing a biologically active agent and the preparation thereof |
| 05/29/2002 | EP1207814A1 Method for producing improved medical devices and devices so produced |
| 05/29/2002 | EP1207810A1 Thrombosis filter having a surface treatment |
| 05/28/2002 | US6395800 Blend of 2-(methacryloyloxyethyl)-2*-(trimethylammonium)ethyl phosphate polymer; medical equipment, catheters; biocompatibility |
| 05/28/2002 | US6395226 Alkoxysilane/alkysilane copolymer coating of medical devices |
| 05/23/2002 | WO2001080919A3 Poly-tri-fluoro-ethoxypolyphosphazene coverings and films |
| 05/23/2002 | US20020061852 Methods of therapy with thrombin derived peptides |
| 05/22/2002 | EP1206946A1 Medical materials and process for producing the same |
| 05/21/2002 | US6391403 Oxygen scavenger; zeolite absorber reduces migration of odor causing byproducts of the oxygen scavenger; food |
| 05/16/2002 | WO2002038649A2 Two dimensional polyamides prepared from unsaturated carboxylic acids and amines |
| 05/15/2002 | EP0964708B1 Biocompatible lubricious hydrophilic materials for medical devices |
| 05/15/2002 | CN1348822A Making process of dextran gel embolism microball |
| 05/14/2002 | US6387379 Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
| 05/10/2002 | WO2002036841A2 Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite |
| 05/10/2002 | WO2002035992A2 Tissue-engineered vascular structures |
| 05/10/2002 | CA2426819A1 Tissue-engineered vascular structures |
| 05/09/2002 | US20020055721 Biocompatible pharmaceutical articles |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/09/2002 | US20020054851 32P-Polyphosphazenes |
| 05/02/2002 | WO2002034312A1 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
| 05/02/2002 | WO2001043790A3 Medical article with a diamond-like carbon coating |
| 05/02/2002 | US20020052627 Devices configured from heat shaped, strain hardened nickel-titanium |
| 05/02/2002 | US20020052448 Process for the surface modification of a polymer substrate and polymers formed therefrom |
| 05/02/2002 | US20020052357 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 05/02/2002 | US20020051730 Coated medical devices and sterilization thereof |
| 05/02/2002 | EP1199991A1 A cutting blade for a surgical instrument |
| 05/02/2002 | EP1019102B1 32 p - polyphosphazene - radiolabelled antithrombogenic polymer |
| 04/30/2002 | US6379740 Depressurization; saturation with brine solution |
| 04/30/2002 | US6379368 Occlusion device with non-thrombogenic properties |
| 04/30/2002 | CA2093819C Platelet adhesion inhibitor |
| 04/24/2002 | EP1199104A2 Medical article having blood-contacting surface |
| 04/24/2002 | CN1083455C photocurable glycosminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 04/24/2002 | CN1083295C Molecular tailoring of surfaces |
| 04/23/2002 | US6375680 Substrates for forming synthetic tissues |
| 04/23/2002 | US6375613 Prognostic testing of organs intended for transplantation |
| 04/23/2002 | CA2087102C Anti-thrombogenic and/or anti-microbial composition |
| 04/18/2002 | CA2359258A1 Medical article having blood-contacting surface |
| 04/17/2002 | EP1196390A2 Pyrazole compositions useful as inhibitors of erk |
| 04/17/2002 | CN1345209A Ladder-type expandable stent |
| 04/16/2002 | US6372814 Non-oxidizing polymeric medical implant |
| 04/16/2002 | US6372283 Depositing oxygen-containing, silicon-containing film forming monomer on pyrolytic carbon surface wherein film forming monomer is a siloxane, priming surface with silane compound; prosthetic heart valves |
| 04/11/2002 | US20020042378 Drug delivery; biocompatible polymer |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/10/2002 | EP0939779B1 Anion exchange materials and processes |
| 04/09/2002 | US6369168 Introducing functional groups to a polymer |
| 04/04/2002 | WO2002026887A2 Crosslinked polyamide |
| 04/04/2002 | WO2002026281A1 Coated medical devices |
| 04/04/2002 | WO2002026139A1 Coated medical devices |
| 04/04/2002 | WO2002006248A3 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 04/04/2002 | US20020040247 Self-aggregating protein compositions and use as sealants |
| 04/04/2002 | CA2424049A1 Coated medical devices and sterilization thereof |
| 04/04/2002 | CA2424038A1 Coated medical devices |
| 04/03/2002 | EP1192959A2 Antithrombotic surface treating agent and medical apparatus |
| 04/03/2002 | EP1192957A2 Coating for medical devices |
| 04/03/2002 | EP1191937A1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 04/02/2002 | US6365692 Polymers with carboxylate and sulfonate groups for cell proliferation, acrylic acid or methacrylic acid, with sodium styrenesulfonate, methyl methacrylate, butyl methacrylate and styrene |
| 04/02/2002 | US6365245 Zeolite in packaging film |
| 04/02/2002 | US6364893 Stent lining |
| 04/02/2002 | CA2021814C Zirconium alloy-based prosthesis with zirconium oxide or zirconium nitride coating |
| 03/28/2002 | WO2002024051A2 Endoscopic targeting method and system |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | US20020037874 Anticoagulants |
| 03/27/2002 | EP1190726A2 Liquefied embolic materials capable of sol-gel phase transition and their use |
| 03/27/2002 | EP1189623A2 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/27/2002 | CN1341458A Low-temp. extrusion/jet-stacking forming process of structure engineering carrier frame |
| 03/26/2002 | US6361819 Thromboresistant coating method |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341033A Hemocompatible surfaces and method for producing same |
| 03/19/2002 | US6358557 Exposing a substrate to an initiator in solution to generate reactive radical sites on the surface of the substrate; contacting with monomers; graft polymerizing onto substrate by forming covalent bonds between monomer molecules and substrate |
| 03/19/2002 | US6358556 Drug release stent coating |
| 03/14/2002 | WO2001048262A8 Method for forming a tio2-x film on a material surface by using plasma immersion ion implantation and the use thereof |
| 03/14/2002 | US20020032414 Coated implantable medical device |
| 03/13/2002 | EP1185288A1 Hemoactive compositions and methods for their manufacture and use |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | DE10040266A1 Vorrichtung für den Einsatz in der Dialyse An apparatus for use in dialysis |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/06/2002 | EP1183058A1 Anti-infective medical device and production method |
| 03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |
| 03/05/2002 | US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants |
| 02/28/2002 | WO2001080921A3 Native protein mimetic fibers, fiber networks and fabrics for medical use |
| 02/27/2002 | EP1181903A2 A stent for angioplasty and associated production process |
| 02/27/2002 | EP1181023A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| 02/27/2002 | EP1180986A2 Self-supporting, shaped, three-dimensional biopolymeric materials and methods |
| 02/27/2002 | EP0930900B1 Biocompatibility for solid surfaces |
| 02/27/2002 | CN2478545Y Device for repair of auricular septal defect |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002013882A1 Implants with a phosphazene-containing coating |
| 02/21/2002 | WO2002013880A2 Bonding spacers to polymeric surfaces |
| 02/21/2002 | US20020022615 Cyclic oxyguanidine protease inhibitors |
| 02/20/2002 | EP1180372A1 Dialysis device of PVC-free, transparent, blood-compatible polyolefins which can be assembled in the presence of a solvent |
| 02/19/2002 | US6348152 Medical material containing fluorinated polysulfone having excellent antithrombotic activity |
| 02/19/2002 | CA2074730C Immobilized polyethylene oxide star molecules for bioapplications |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2001085249B1 A catheter lock solution including a photo-oxidant |
| 02/14/2002 | US20020018903 Overcoating titanium, or alloy thereof, with alkali metal titanate |